Gorman Steven H
Drug Safety and Disposition Department, Cephalon, Inc, West Chester, PA 19380-4245, USA.
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Feb 15;767(2):269-76. doi: 10.1016/s1570-0232(01)00572-4.
An assay was developed to determine concentrations of modafinil (dl-2-[(diphenylmethyl)sulfinyl]acetamide; Provigil) and its two major circulating metabolites, modafinil acid and modafinil sulfone, in human plasma. The assay utilized liquid-liquid extraction of the analytes and an internal standard, (phenylthio)acetic acid, from plasma into a mixture of hexane-dichloromethane-glacial acetic acid (55:45:2, v/v). The analytes were resolved isocratically on a narrow-bore phenyl column at a mobile phase flow-rate of 0.3 ml/min and were monitored by UV detection at 235 nm. The method reported herein reduces the required sample volume of previously reported methods from 1.00 to 0.200 ml of plasma while lowering the limit of quantification (LOQ). The linear range of the assay was from 0.100 to 20.0 microg/ml for each of the three compounds.
已开发出一种测定人血浆中莫达非尼(dl-2-[(二苯甲基)亚磺酰基]乙酰胺;普罗文奇)及其两种主要循环代谢物莫达非尼酸和莫达非尼砜浓度的分析方法。该分析方法利用液-液萃取法,从血浆中提取分析物和内标(苯硫基)乙酸,使其进入己烷-二氯甲烷-冰醋酸(55:45:2,v/v)的混合物中。分析物在窄孔苯基柱上以0.3 ml/min的流动相流速等度洗脱,并通过235 nm处的紫外检测进行监测。本文报道的方法将先前报道方法所需的血浆样本体积从1.00 ml减少到0.200 ml,同时降低了定量限(LOQ)。三种化合物中每种化合物的分析线性范围均为0.100至20.0 μg/ml。